Transgene Biotek Ltd. Capital Structure Analysis

From Year - To Year	Class Of Share	Authorized Capital (Crores)	Issued Capital (Crores)	Paid Up Shares (Nos)	Paid Up Face Value	Paid Up Capital (Crores)
2015 - 2016	Equity Share	76	75.77	7,57,70,000	10	75.77
2014 - 2015	Equity Share	75.77	75.77	7,57,70,000	10	75.77
2013 - 2014	Equity Share	76	75.77	7,57,70,000	10	75.77
2012 - 2013	Equity Share	75	65.77	6,57,70,000	10	65.77
2011 - 2012	Equity Share	75	65.77	6,57,70,000	10	65.77
2010 - 2011	Equity Share	75	40.77	4,07,70,000	10	40.77
2009 - 2010	Equity Share	20	15.02	1,50,20,000	10	15.02
2008 - 2009	Equity Share	20	15.77	1,57,70,000	10	15.77
2007 - 2008	Equity Share	20	15.02	1,50,20,000	10	15.02
2006 - 2007	Equity Share	20	15.02	1,50,20,000	10	15.02

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article